Treatment of Intermediate-stage Hepatocellular Carcinoma
Status:
Unknown status
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of transarterial
chemoembolization (TACE) combined with arginine hydrochloride and trimetazidine hydrochloride
tablets in the treatment of patients with hepatocellular carcinoma.
Phase:
Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University
Collaborators:
Anyang Tumor Hospital First Affiliated Hospital of Xinjiang Medical University First People's Hospital of Shangqiu Jiaozuo third people's hospital Luoyang Central Hospital Nanyang Central Hospital Shenma Medical Group General Hospital